“2022 Cancer Facts and Figures.” [Online]. Available: https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html

Singhi, A. D., Koay, E. J., Chan, S. T., & Maitra, A. (2019). Early detection of pancreatic cancer: Opportunities and challenges. Gastoenterology, 156, 2024–2040. https://doi.org/10.1053/j.gastro.2019.01.259

Article  Google Scholar 

Waters, A. M., & Der, C. J. (2018). KRAS: The critical driver and therapeutic target for pancreatic cancer. Cold Spring Harbor Perspectives in Medicine, 8(9), 1–17. https://doi.org/10.1101/cshperspect.a031435

Article  CAS  Google Scholar 

. (2021). FDA Approves First KRAS Inhibitor: Sotorasib. Cancer Discover, 11(8), OF4 LP-OF4. https://doi.org/10.1158/2159-8290.CD-NB2021-0362

Canon, J., et al. (2019). The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature, 575(7781), 217–223. https://doi.org/10.1038/s41586-019-1694-1

Article  PubMed  CAS  Google Scholar 

Skoulidis, F., et al. (2021). Sotorasib for lung cancers with KRAS p.G12C mutation. New England Journal of Medicine, 384(25), 2371–2381. https://doi.org/10.1056/nejmoa2103695

Article  PubMed  CAS  Google Scholar 

Quiñonero, F., et al. (2019). The challenge of drug resistance in pancreatic ductal adenocarcinoma: A current overview. Cancer Biology and Medicine, 16(4), 688–699. https://doi.org/10.20892/j.issn.2095-3941.2019.0252

Article  PubMed  PubMed Central  CAS  Google Scholar 

Conroy, T., et al. (2011). FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. New England Journal of Medicine, 364(19), 1817–1825. https://doi.org/10.1056/nejmoa1011923

Article  PubMed  CAS  Google Scholar 

Lauria, G., et al. (2023). Role of mitochondrial transporters on metabolic rewiring of pancreatic adenocarcinoma: A comprehensive review. Cancers, 15(2) MDPI. https://doi.org/10.3390/cancers15020411

Reyes-Castellanos, G., Masoud, R., & Carrier, A. (2020). Mitochondrial metabolism in PDAC: From better knowledge to new targeting strategies. Biomedicines, 8(8) MDPI AG. https://doi.org/10.3390/BIOMEDICINES8080270

Ying, H., et al. (2012). Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell, 149(3), 656–670. https://doi.org/10.1016/j.cell.2012.01.058

Article  PubMed  PubMed Central  CAS  Google Scholar 

Son, J., et al. (2013). Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature, 496(7443), 101–105. https://doi.org/10.1038/nature12040

Article  PubMed  PubMed Central  CAS  Google Scholar 

Masoud, R., et al. (2020). Targeting mitochondrial complex I overcomes chemoresistance in high OXPHOS pancreatic cancer. Cell Reports Medicine, 1(8). https://doi.org/10.1016/j.xcrm.2020.100143

Daemen, A., et al. (2015). Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. Proceedings of the National Academy of Sciences, 112(32), E4410–E4417. https://doi.org/10.1073/pnas.1501605112

Article  CAS  Google Scholar 

Viale, A., et al. (2014). Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature, 514(7524), 628–632. https://doi.org/10.1038/nature13611

Article  PubMed  PubMed Central  CAS  Google Scholar 

Raho, S., et al. (2020). KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth. Nature Metabolism, 2(12), 1373–1381. https://doi.org/10.1038/s42255-020-00315-1

Article  PubMed  CAS  Google Scholar 

Sancho, P., et al. (2015). MYC/PGC-1α balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells. Cell metabolism, 22(4), 590–605. https://doi.org/10.1016/j.cmet.2015.08.015

Article  PubMed  CAS  Google Scholar 

Molina, J. R., et al. (2018). An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nature Medicine, 24(7), 1036–1046. https://doi.org/10.1038/s41591-018-0052-4

Article  PubMed  CAS  Google Scholar 

Yap, T. A., et al. (2023). Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: Phase I trials. Nature Medicine, 29(1), 115–126. https://doi.org/10.1038/s41591-022-02103-8

Article  PubMed  CAS  Google Scholar 

Kordes, S., et al. (2015). Metformin in patients with advanced pancreatic cancer: A double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncology, 16(7), 839–847. https://doi.org/10.1016/S1470-2045(15)00027-3

Article  PubMed  CAS  Google Scholar 

Li, W., Nichols, K., Nathan, C. A., & Zhao, Y. (2013). Mitochondrial uncoupling protein 2 is up-regulated in human head and neck, skin, pancreatic, and prostate tumors. Cancer Biomarkers, 13(5), 377–383. https://doi.org/10.3233/CBM-130369

Article  PubMed  CAS  Google Scholar 

Ayyasamy, V., et al. (2011). Cellular model of Warburg Effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipin. PLoS One, 6(9). https://doi.org/10.1371/journal.pone.0024792

Aguilar, E., et al. (2019). UCP2 deficiency increases colon tumorigenesis by promoting lipid synthesis and depleting NADPH for antioxidant defenses. Cell Rep, 28(9), 2306–2316.e5. https://doi.org/10.1016/j.celrep.2019.07.097

Article  PubMed  PubMed Central  CAS  Google Scholar 

Harper, M.-E., et al. (2002). Characterization of a novel metabolic strategy used by drug-resistant tumor cells. The FASEB Journal, 16.

Derdak, Z., Mark, N. M., Beldi, G., Robson, S. C., Wands, J. R., & Baffy, G. (2008). The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. Cancer Research, 68(8), 2813–2819. https://doi.org/10.1158/0008-5472.CAN-08-0053

Article  PubMed  PubMed Central  CAS  Google Scholar 

Palmieri, F. (2013). The mitochondrial transporter family SLC25: Identification, properties and physiopathology. Molecular Aspects of Medicine, 34(2–3), 465–484. https://doi.org/10.1016/j.mam.2012.05.005

Article  PubMed  CAS  Google Scholar 

Gorgoglione, R., et al. (2019). The human uncoupling proteins 5 and 6 (UCP5/SLC25A14 and UCP6/SLC25A30) transport sulfur oxyanions, phosphate and dicarboxylates. Biochim Biophys Acta Bioenerg, 1860(9), 724–733. https://doi.org/10.1016/j.bbabio.2019.07.010

Article  PubMed  CAS  Google Scholar 

Ricquier, D., & Bouillaud, F. (2000). The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochemical Journal, 345(2), 161–179. https://doi.org/10.1042/0264-6021:3450161

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bouillaud, F., Weissembach, J., & Ricquier, D. (1986). Complete cDNA-derived amino acid sequence of rat brown fat uncoupling protein. Journal of Biological Chemistry, 261(4), 1487–1490.

Article  PubMed  CAS  Google Scholar 

Nicholls, D., Bernson, V., & Heaton, G. (1978). The identification of the component in the inner membrane of brown adipose tissue mitochondria responsible for regulating energy dissipation. Experientia Supply, 32, 89–93.

Article  CAS  Google Scholar 

Enerback, S., et al. (1997). Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature Letters, 387.

Fleury, C., et al. (1997). Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nature Genetics, 15, 269–272.

Article  PubMed  CAS  Google Scholar 

Gimeno, R. E., et al. (1997). Cloning and characterization of an uncoupling protein homolog: A potential molecular mediator of human thermogenesis. Diabetes, 46(5), 900–906. https://doi.org/10.2337/diab.46.5.900

Article  PubMed  CAS  Google Scholar 

Arsenijevic, D., et al. (2000). Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet, 26(4), 435–439. https://doi.org/10.1038/82565

Article  PubMed  CAS  Google Scholar 

N. Tu et al., “Structural organization and mutational analysis of the human uncoupling protein-2 (hUCP2) GENE,” 1999.

Google Scholar 

Pecqueur, C., et al. (2001). Uncoupling protein 2, in Vivo distribution, induction upon oxidative stress, and evidence for translational regulation. Journal of Biological Chemistry, 276(12), 8705–8712. https://doi.org/10.1074/jbc.M006938200

Article  PubMed  CAS  Google Scholar 

Alán, L., Smolková, K., Kronusová, E., Šantorová, J., & Ježek, P. (2009). Absolute levels of transcripts for mitochondrial uncoupling proteins UCP2, UCP3, UCP4, and UCP5 show different patterns in rat and mice tissues. Journal of Bioenergetics and Biomembranes, 41(1), 71–78. https://doi.org/10.1007/s10863-009-9201-2

Article  PubMed  CAS  Google Scholar 

Berardi, M. J., Shih, W. M., Harrison, S. C., & Chou, J. J. (2011). Mitochondrial uncoupling protein 2 structure determined by NMR molecular fragment searching. Nature, 476(7358), 109–114. https://doi.org/10.1038/nature10257

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jezek, P., Holendova, B., Garlid, K. D., & Jaburek, M. (2018). Mitochondrial uncoupling proteins: Subtle regulators of cellular redox signaling. Antioxidants & Redox Signaling, 29, 667–714.

CAS  Google Scholar 

Fedorenko, A., Lishko, P. V., & Kirichok, Y. (2012). Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell, 151(2), 400–413. https://doi.org/10.1016/j.cell.2012.09.010

Article  PubMed  PubMed Central  CAS